Author:
Ling Jing,Shi Jun,Jiang Qiudi,Jiao Zheng
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,General Medicine
Reference45 articles.
1. USRDS (2013) Annual data report: Atlas of chronic kidney disease and end-stage renal disease in the United States, (2013) National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. http://www.usrds.org/2013/pdf/v2_ch7_13.pdf . Accessed 7 Oct 2014
2. Allison AC, Eugui EM (2000) Mycophenolate mofetil and its mechanisms of action. Immunopharmacology 47(2–3):85–118
3. Bullingham RE, Nicholls AJ, Kamm BR (1998) Clinical pharmacokinetics of mycophenolate mofetil. Clin Pharmacokinet 34(6):429–455
4. Picard N, Ratanasavanh D, Premaud A, Le Meur Y, Marquet P (2005) Identification of the UDP-glucuronosyltransferase isoforms involved in mycophenolic acid phase II metabolism. Drug Metab Dispos 33(1):139–146. doi: 10.1124/dmd.104.001651
5. Staatz CE, Tett SE (2007) Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients. Clin Pharmacokinet 46(1):13–58. doi: 10.2165/00003088-200746010-00002
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献